Growblox Sciences, Inc. (OTCQB: GBLX) is rapidly approaching
the impending commencement of cultivation operations through its majority-owned
subsidiary, GB Sciences Nevada, LLC. As a result, the company has turned much
of its attention in recent weeks toward transitioning from an engineering
intensive development stage to the day-to-day operations related to the
production and branding of its innovative products. Among these efforts,
Growblox has made significant progress in beefing up its staff to meet the
increased demands of production efforts while simultaneously promoting
sustainable revenue growth.
In July, the company announced the hiring of John Poss as a
consultant. Poss brings more than 15 years of consulting experience to the
Growblox team, as well as the knowledge gained from operating as a CEO, COO,
CFO and CTO of both public and private firms with sales of up to $450 million.
In August, the company built upon this relationship by appointing Poss as its
new chief financial officer. Following this announcement, Growblox will look to
lean on its newest executive’s considerable industry expertise in order to
promote a smooth and expeditious strategic transition.
“First joining us as a consultant, the performance of John
Poss and his impact on our company, made the hiring of him as a full-time key
executive an obvious choice,” Craig Ellins, chief executive officer of
Growblox, stated in a news release. “This choice supports our transition from
the engineering intensive development stage to the day-to-day operations of
producing an excellent product, branding it appropriately, and maximizing our
revenue.”
While it continues to increase the size of its staff,
Growblox is currently progressing toward the completion of its new cultivation
facility, which will provide a pristine and consistent environment for growing
and processing medical cannabis that will also safeguard the company’s
proprietary technology and equipment. As of its latest update, Growblox plans
to complete construction of the facility before the end of 2015, strategically
positioning it to initiate revenue-generating operations as early as next year.
In preparation, GB Sciences Nevada has already applied for certification to
dispense medical cannabis at two locations in Clark County, Nevada, and it is
currently awaiting approval.
With the considerable progress of GB Sciences, as well as
the company’s ongoing efforts to finalize the production and testing of its
groundbreaking GrowBLOX Suites system in 2016, Growblox is in a favorable position
to capitalize on the nation’s thriving cannabis industry in order to promote
rapid financial growth in the future.
For more information, visit www.growblox.com
About QualityStocks
QualityStocks
is committed to connecting subscribers with companies that have huge potential
to succeed in the short and long-term future. We offer several ways for
investors to find, evaluate, and learn more about investing in these companies.
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment